Published in Br J Clin Pharmacol on December 01, 1984
Excretion of cyclosporine and its metabolites in human bile. Transplant Proc (1986) 1.27
Cyclosporin-phenytoin interaction: re-evaluation using metabolite data. Br J Clin Pharmacol (1987) 1.07
Lack of effect of spiramycin on cyclosporin pharmacokinetics. Br J Clin Pharmacol (1989) 0.96
Cyclosporin-erythromycin interaction in normal subjects. Br J Clin Pharmacol (1987) 0.92
Cyclosporine trough concentration monitoring in liver transplant patients. Transplant Proc (1986) 0.88
Erythromycin enhances the absorption of cyclosporin. Br J Clin Pharmacol (1988) 0.87
Interaction between cyclosporin A and phenobarbitone. Br J Clin Pharmacol (1986) 0.85
Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography. Transplant Proc (1986) 0.82
The effect of vehicle on the oral absorption of cyclosporin. Br J Clin Pharmacol (1986) 0.81
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches. Cell Mol Immunol (2016) 0.77
The effect of diphenyl-dimethyl-dicarboxylate on cyclosporine-A blood level in kidney transplants with chronic hepatitis. Korean J Intern Med (1997) 0.75
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology (1977) 7.10
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet (1980) 4.21
A radioimmunoassay to measure cyclosporin A in plasma and serum samples. J Immunoassay (1981) 2.55
Immunological and pharmacological monitoring in the clinical use of cyclosporin A. Lancet (1981) 1.77
Intravenous cyclosporine kinetics in renal failure. Clin Pharmacol Ther (1983) 1.73
Simplified liquid-chromotographic analysis for cyclosporin A, and comparison with radioimmunoassay. Clin Chem (1983) 1.38
Rapid metabolism of cyclosporin and prednisone in kidney transplant patient receiving tuberculostatic treatment. Lancet (1983) 1.13
Cyclosporine for treatment of early type I diabetes: preliminary results. N Engl J Med (1983) 1.10
Cyclosporin A: a powerful immunosuppressant. Can Med Assoc J (1982) 1.09
Enzyme induction by drugs. Its relevance to clinical biochemistry. Ann Clin Biochem (1978) 1.09
Enzyme induction (third of three parts). N Engl J Med (1976) 1.01
High-performance liquid chromatographic determination of cyclosporin A in human plasma and urine. J Chromatogr (1980) 0.87
Cyclosporin-A prophylactic treatment of graft-versus-host disease in human allogeneic bone marrow transplantation: preliminary results. Transplant Proc (1981) 0.83
Monitoring of cyclosporin A: is it possible? Ther Drug Monit (1983) 0.83
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
The Canadian CT Head Rule for patients with minor head injury. Lancet (2001) 7.91
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med (1995) 7.83
The Canadian C-spine rule for radiography in alert and stable trauma patients. JAMA (2001) 7.48
Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol (1991) 6.55
The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol (1995) 6.08
Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. CMAJ (1989) 4.76
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA (1999) 4.31
A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med (1993) 3.67
Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science (1984) 3.47
Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst Monogr (1999) 3.45
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2007) 3.28
The Ottawa patient decision aids. Eff Clin Pract (1999) 3.22
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther (1976) 3.16
Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials (1999) 2.99
Evidence-based medicine and the practicing clinician. J Gen Intern Med (1999) 2.99
Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet (2000) 2.90
Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1992) 2.81
Variation in emergency department use of cervical spine radiography for alert, stable trauma patients. CMAJ (1997) 2.79
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Antithrombotic therapy in atrial fibrillation. Chest (2001) 2.62
Clinical recommendations using levels of evidence for antithrombotic agents. Chest (1995) 2.52
Multicentre trial to introduce the Ottawa ankle rules for use of radiography in acute ankle injuries. Multicentre Ankle Rule Study Group. BMJ (1995) 2.50
Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg (1998) 2.44
The rational clinical examination. Does this patient have a clinically important carotid bruit? JAMA (1993) 2.38
Dictated versus database-generated discharge summaries: a randomized clinical trial. CMAJ (1999) 2.28
What is the quality of life for survivors of cardiac arrest? A prospective study. Acad Emerg Med (1999) 2.27
Initiating, conducting and maintaining guidelines development programs. CMAJ (1993) 2.24
Antithrombotic therapy in atrial fibrillation. Chest (1992) 2.21
A cumulative meta-analysis of the effectiveness of defibrillator-capable emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med (1999) 2.19
Warfarin for atrial fibrillation. The patient's perspective. Arch Intern Med (1996) 2.18
Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am J Pathol (1993) 2.16
Antithrombotic therapy in atrial fibrillation. Chest (1995) 2.08
Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope (1999) 2.08
Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med (1999) 2.07
Xylazine hydrochloridine (Rompun) overdose in man. Clin Toxicol (1979) 2.00
Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med (2001) 1.82
Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81
Immunological and pharmacological monitoring in the clinical use of cyclosporin A. Lancet (1981) 1.77
Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade. Clin Pharmacol Ther (1977) 1.77
Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol (1976) 1.71
Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med (1998) 1.68
Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis (1990) 1.67
The Canadian CT Head Rule Study for patients with minor head injury: rationale, objectives, and methodology for phase I (derivation). Ann Emerg Med (2001) 1.65
The use of consensus guidelines for management of cytomegalovirus infection in renal transplantation. Kidney Int (2007) 1.57
The cost impact of cytomegalovirus disease in renal transplant recipients. Transplantation (1993) 1.55
Evaluation of a decision aid for patients considering autologous blood donation before open-heart surgery. CMAJ (2001) 1.54
When should hypertension be treated? The different perspectives of Canadian family physicians and patients. CMAJ (2000) 1.51
Cyclosporin prevents diabetes in BB Wistar rats. Lancet (1983) 1.50
Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation. Bone Marrow Transplant (2000) 1.49
Simple bioequivalence criteria: are they relevant to critical dose drugs? Experience gained from cyclosporine. Ther Drug Monit (1997) 1.48
Asymptomatic Wolff-Parkinson-White. Should we intervene? Circulation (1989) 1.47
Plasma digoxin concentrations in patients on admission to hospital. Br Heart J (1974) 1.46
Autologous versus allogeneic transfusion: patients' perceptions and experiences. CMAJ (1999) 1.45
An economic analysis of the Ottawa knee rule. Ann Emerg Med (1999) 1.43
Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators. N Engl J Med (1994) 1.43
Biomarkers in transplantation: Prospective, blinded measurement of predictive value for the flow cytometry crossmatch after negative antiglobulin crossmatch in kidney transplantation. Kidney Int (2006) 1.42
Randomised study of n of 1 trials versus standard practice. BMJ (1996) 1.41
A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg (1999) 1.40
Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis (1994) 1.40
What will increase the number of organs for transplantation? Some strategies to consider. CMAJ (1994) 1.39
The effects and side effects of cyclosporine: relationship to drug pharmacokinetics. Transplant Proc (1982) 1.38
Simplified liquid-chromotographic analysis for cyclosporin A, and comparison with radioimmunoassay. Clin Chem (1983) 1.38
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2001) 1.37
The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir. J Infect Dis (1991) 1.34
Duration of action of beta-blocking drugs. Br Med J (1973) 1.33
How well is the clinical importance of study results reported? An assessment of randomized controlled trials. CMAJ (2001) 1.31
Variation in ED use of computed tomography for patients with minor head injury. Ann Emerg Med (1997) 1.29
Variability in prescription drug utilization: issues for research. CMAJ (1996) 1.24
Calcium movement in vascular smooth muscle and its detection using lanthanum as a tool. Can J Physiol Pharmacol (1973) 1.24
Development of a decision aid for atrial fibrillation who are considering antithrombotic therapy. J Gen Intern Med (2000) 1.23
Cost-effectiveness analysis of potential improvements to emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med (1996) 1.21
Awareness and use of the Ottawa ankle and knee rules in 5 countries: can publication alone be enough to change practice? Ann Emerg Med (2001) 1.19
Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg (1998) 1.17
Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest (1998) 1.16
Canadian Consensus Meeting on cyclosporine monitoring: report of the consensus panel. Clin Chem (1990) 1.16
Tolerance to nicotinic acid flushing. Clin Pharmacol Ther (1991) 1.15
Effectiveness of emergency medical services for victims of out-of-hospital cardiac arrest: a metaanalysis. Ann Emerg Med (1996) 1.15
Quinidine-rifampin interaction. N Engl J Med (1981) 1.14
HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr (2000) 1.14
Measurement of partial agonist activity of pindolol. Clin Pharmacol Ther (1981) 1.13
Cost-effectiveness analysis of the Ottawa Ankle Rules. Ann Emerg Med (1995) 1.13
Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration. Postgrad Med J (1977) 1.13
Cyclosporine for treatment of early type I diabetes: preliminary results. N Engl J Med (1983) 1.10